Dapagliflozin 10mg + Metformin 500mg SR
Dapagliflozin causes urinary glucose excretion via SGLT-2 inhibition. Metformin reduces liver glucose output and insulin resistance. Together they provide complementary control of blood sugar, weight, and blood pressure.
Type 2 diabetes inadequately controlled on Metformin alone with cardiovascular or renal risk factors.
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
DAPDOZ M adds Dapagliflozin's glucose-lowering, weight-reducing, and cardiorenal protection to Metformin therapy — a powerful combination for patients with Type 2 diabetes and cardiovascular or kidney risk.
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.